International Patent: COMBINATIONS OF VEPDEGESTRANT AND CDK4/6 INHIBITORS FOR TREATING ESR1-MUTANT BREAST CANCER

GENEVA, July 1 -- ARVINAS OPERATIONS, INC. filed a patent application (US2025/058640) for “COMBINATIONS OF VEPDEGESTRANT AND CDK4/6 INHIBITORS FOR TREATING ESR1-MUTANT BREAST CANCER”. With publication no. WO/2026/128391, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 31/496

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....